Obama''s inversion curbs kill Pfizer''s $160 bln Allergan deal

Obama''s inversion curbs kill Pfizer''s $160 bln Allergan deal

U.S. drug maker Pfizer Inc agreed on Tuesday to terminate its $160 billion agreement to acquire Botox maker Allergan Plc, in a major victory to U.S. President Barack Obama`s drive to stop tax-dodging corporate mergers.

FDCs banned over safety & efficacy concerns: Centre tells HC

The hearing in the matter would continue on April 4.  

Pfizer appoints S Sridhar as MD

"The Board of Directors of the company has appointed S Sridhar as the Managing Director of the company, with effect from March 18, 2016 for a period of five years," Pfizer Ltd said in a BSE filing.

Delhi HC stays ban on sale of P&G's Vicks Action 500 till March 21

The court granted the relief to P&G, after having given similar reliefs in the past two days to pharma major Pfizer's cough syrup 'Corex' and Abbott Healthcare and Macleods Pharmaceuticals whose certain combination medicines were banned by the Health Ministry.

After Pfizer, HC grants relief to Abbott and Macleods

After Pfizer, HC grants relief to Abbott and Macleods

Pharma majors Abbott Healthcare and Macleods Pharmaceuticals Tuesday got interim relief from the Delhi High Court which stayed till March 21 Government's decision banning sale of certain combination medicines of the two companies.

After Pfizer, HC grants relief to Abbott and Macleods

The Health Ministry, through a gazette notification, has banned over 300 fixed dose combination drugs, including cough syrups compositions, saying they involve "risk" to humans and safer alternatives were available.

Delhi HC stays ban on sale of cough syrup Corex

Pfizer has discontinued manufacture and sale of popular cough syrup Corex with immediate effect after the Health Ministry banned around 350 fixed dose combination drugs.

Pfizer stops sale of cough syrup Corex after govt ban, stock falls

Pfizer stops sale of cough syrup Corex after govt ban, stock falls

Pharmaceutical major Pfizer has discontinued manufacture and sale of popular cough syrup Corex with immediate effect after the government banned fixed dose combination of Chlopheniramine Maleate+ Codeine Syrup.

 

Pfizer shares zoom nearly 9% on Allergen deal

Shares of Pfizer Ltd rose sharply by nearly 9 percent Tuesday after its parent Pfizer Inc's announcement to buy Botox manufacturer Allergan in a record USD 160 billion deal, a biggest buyout in the global healthcare sector.

 

Pfizer withdraws notice to close Thane plant

Drug firm Pfizer has withdrawn its notice to close its Thane plant as it has entered into an agreement to sell the facility as a going concern to Vidhi Research and Development LLP.

India rejects Pfizer's patent application for arthritis drug

India's patent office has again rejected US drug major Pfizer's new patent application for its rheumatoid arthritis medicine, tofacitinib, citing it did not enhance the efficacy of the existing approved drug.

Pfizer lifts forecast despite hit from strong dollar

Pfizer reported a dip in second-quarter profits Tuesday, but boosted its forecast due in part to higher revenues from cancer drugs and global vaccines.

Pfizer's June quarter net grows 43% to Rs 54 crore

Drug maker Pfizer on Saturday posted a 43.43 percent rise in its net profit at Rs 53.83 crore for the first quarter ended June.

Pfizer to close its Navi Mumbai plant

Drug firm Pfizer is planning to close its Navi Mumbai plant from September 16, 2015.

Pfizer reports Q4 net profit at Rs 42.68 crore

Drug firm Pfizer Tuesday reported a standalone net profit of Rs 42.68 crore for the quarter ended March 31, 2015.

New York`s Cuomo in Cuba meets business, religious leaders

 New York state Governor Andrew Cuomo met with Cuban officials and business and religious leaders Monday in Havana on a whirlwind tour with a delegation of US executives.

Pfizer stops sale of children's vaccine in China

American pharmaceutical giant Pfizer has stopped selling one of its lucrative vaccines for children in China, the company said.

Pfizer to acquire Hospira at enterprise value of $17 bn

Pfizer to acquire Hospira at enterprise value of $17 bn

This is Pfizer's biggest acquisition after its failed USD 117 billion takeover bid for UK-based pharmaceuticals firm AstraZeneca in May last year.

Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bn

Pfizer is to cut the price of its pneumococcal vaccine Prevenar 13 by 6 percent to $3.10 per dose in poor countries as part of a commitment to the GAVI global vaccines alliance, the US drugmaker said on Monday.

Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bn

Pfizer is to cut the price of its pneumococcal vaccine Prevenar 13 by 6 percent to $3.10 per dose in poor countries as part of a commitment to the GAVI global vaccines alliance, the U.S. drugmaker said on Monday.